NEW ORLEANS – Ochsner MD Anderson Cancer Center announces it has earned two accreditations and a recognition that reflects its commitment to comprehensive, expert, multidisciplinary cancer care.
Accreditation and recognition
- Eight Ochsner MD Anderson locations have received accreditation under the American College of Surgeons (ACS) Commission on Cancer (CoC) Accreditation Program. Locations include:
- The Gayle and Tom Benson Cancer Center at Ochsner Medical Center
- Ochsner Baptist – A Campus of Ochsner Medical Center
- Ochsner Medical Center – Kenner
- Ochsner Medical Center – West Bank Campus
- Ochsner Cancer Center – Baton Rouge
- Ochsner Medical Complex – The Grove
- Slidell Regional Cancer Center – A Campus of Ochsner Medical Center
- St. Tammany Cancer Center – A Campus of Ochsner Medical Center
- Two locations, the Lieselotte Tansey Breast Cancer Center at Ochsner MD Anderson and Ochsner MD Anderson Cancer Center at St. Tammany Cancer Center – A campus of Ochsner Medical Center, have received accreditation under the American College of Surgeons (ACS) National Accreditation Program for Breast Center (NAPBC).
- Accreditation from ACS is issued every three years. Ochsner MD Anderson and St. Tammany Cancer – A campus of Ochsner Medical Center have previously received accreditations.
- Additionally, Ochsner MD Anderson’s The Gayle and Tom Benson Cancer Center has been recognized as the first and only listed sarcoma treatment center in Louisiana by the Sarcoma Foundation of America and the Sarcoma Alliance for Research through Collaboration.
Together, these recognitions illustrate Ochsner MD Anderson’s focus on delivering coordinated comprehensive cancer care from prevention and screening to diagnosis, treatment and survivorship. Ochsner MD Anderson’s multidisciplinary approach brings together specialists across cancer disciplines to support patients with complex and varied needs.
Commission on Cancer (CoC) Accreditation Program
The ACS CoC is a consortium of professional organizations dedicated to improving survival and quality of life for patients with cancer by setting and raising standards.
CoC accreditation is granted to institutions committed to providing high-quality cancer care by demonstrating compliance with CoC standards. Each cancer program must undergo a rigorous evaluation and review of its performance and compliance with CoC standards. To maintain accreditation, cancer programs must undergo a site visit every three years. The CoC accreditation standards supply the structure for providing all patients with a full range of diagnostic, treatment, and supportive services either on-site or by referral, including community-based resources.
National Accreditation Program for Breast Center (NAPBC)
Breast cancer is the most common cancer diagnosed in women in the U.S. after skin cancers. Programs accredited by NAPBC follow a model for organizing and managing a breast center to facilitate multidisciplinary, integrated, and comprehensive breast cancer services. The NAPBC focuses on the spectrum of a patient’s journey with breast cancer or breast disease, including prevention, screening, treatment and survivorship. By setting high standards, NAPBC accreditation guides breast centers in providing comprehensive breast care based on scientific evidence.
As a CoC-accredited institution and an NAPBC-accredited institution, Ochsner MD Anderson and the Lieselotte Tansey Breast Cancer Center also become an ACS Surgical Quality Partner. Being a Surgical Quality Partner signifies an institution’s dedication to consistently improving procedures and approaches, while maintaining a critical eye on process at every step. The Surgical Quality Partner designation lets patients know Ochsner MD Anderson and the Lieselotte Tansey Breast Cancer Center are dedicated to quality and relentless self-improvement and has been verified or accredited by ACS. Patients can trust that the care they receive at Surgical Quality Partner hospitals adheres to the most rigorous standards in surgical quality.
“ACS Quality programs are grounded in more than a century of experience and participation is an important measure of a hospital’s surgical quality. As an ACS Surgical Quality Partner, Ochsner MD Anderson has shown a commitment to providing the best possible patient care, evaluating that care in a rigorous fashion, and dedicating themselves to continuous self-improvement,” said ACS Executive Director & Chief Executive Officer Patricia L. Turner, MD, MBA, FACS.
Sarcoma Treatment Center
Recognition by the Sarcoma Foundation of America and the Sarcoma Alliance for Research through Collaboration as a Sarcoma Treatment Center highlights Ochsner MD Anderson’s distinguished expertise in sarcoma care. Ochsner MD Anderson provides specialized sarcoma care including a multidisciplinary program in which specialists in oncology, orthopedics, radiology, and pathology collaborate through regular case review and tumor board discussions, ensuring every patient benefits from collective clinical insight. Patients have access to advanced imaging and diagnostic tools, participation in leading clinical trials and a full range of comprehensive support services.
Expert cancer care in the community
“These milestones are a testament to our commitment to advancing expert, patient-centered care. Patients and families can look at these accreditations and recognition as markers of a cancer program committed to meeting and exceeding nationally recognized standards and continuously enhancing the care experience in their own community, close to home,” said Zoe Larned, MD, director, Ochsner MD Anderson Cancer Center and system chair, hematology/oncology, Ochsner Health.
For more than 80 years, Ochsner has been dedicated to cancer research and new cancer therapy development, bringing innovations to treatment with more clinical trials than anywhere else in Louisiana. It is also accredited by the American Society of Clinical Oncology, the American College of Radiology and the Foundation for the Accreditation of Cellular Therapy (Bone Marrow Transplant).
Cancer care at Ochsner MD Anderson is recognized by U.S. News & World Report, ranking as high performing in leukemia, lymphoma and myeloma treatment and colon, lung and prostate cancer surgeries. The Ochsner Cancer Institute treats more than 40,000 patients each year and has cared for patients from all 50 states and 28 countries. Each patient’s care team can include as many as 20 multidisciplinary cancer specialists working together to provide high-quality treatment.
To learn more about Ochsner MD Anderson and the treatment options available to patients, please visit ochsner.org/cancerservices.
About Ochsner MD Anderson Cancer Center
Ochsner MD Anderson Cancer Center combines the expertise of Ochsner Health, Louisiana’s leader in cancer care, with the world-renowned The University of Texas MD Anderson Cancer Center. As the only fully integrated cancer program in Louisiana based on MD Anderson’s standards and protocols, it offers patients access to cutting-edge treatments, innovative clinical trials, and personalized care plans. With a multidisciplinary team of specialists and advanced technology, Ochsner MD Anderson provides comprehensive care for both common and rare cancers across multiple locations in southeastern Louisiana. This partnership ensures patients receive expert cancer care close to home.
About Ochsner Health
Ochsner Health is the leading nonprofit healthcare provider in Louisiana, Mississippi and across the Gulf South, delivering expert care at its 47 hospitals and more than 370 health and urgent care centers. Ochsner is nationally recognized for inspiring healthier lives and stronger communities through expertise, quality and digital connectivity. In 2025, more than 40,000 dedicated team members and 5,000 employed and affiliated physicians at Ochsner cared for more than 1.6 million people from every state in the nation and 65 countries. To learn more about how Ochsner empowers people to get well and stay well, visit www.ochsner.org.